Tag: mineralocorticoid receptor antagonists

1. In this survey of patients with heart failure, most participants were familiar with angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor blockers (ARB), beta-blockers and diuretics. Fewer patients reported familiarity with angiotensin receptor–neprilysin inhibitors or mineralocorticoid receptor antagonists. 2. Patients commonly reported concerns with regards to the safety profile and effectiveness...